Navigation Links
Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters
Date:10/8/2007

BERKELEY HEIGHTS, N.J., Oct. 8 /PRNewswire/ -- Clinsys Clinical Research, Inc., a therapeutically focused clinical research organization, today announced the relocation of its corporate headquarters to accommodate the company's significant growth and plans for future expansion. The new, larger facility is located in Bedminster, New Jersey.

"Our new headquarters, combined with our recent expansion of operations in Raleigh, North Carolina and Dusseldorf, Germany, offers many advantages to Clinsys and our sponsors," said David E. Williams, Chief Executive Officer of Clinsys Clinical Research. Mr. Williams continues, "The relocation strategically keeps Clinsys in the center of one of the largest biopharmaceutical clusters and experienced employee pools in the country. Our new headquarters will afford us enhanced operational performance from which to continue to provide exceptional service to our existing and new sponsors."

Clinsys will occupy the new facility on Monday, October 15. The new address is:

One Crossroads Drive, Building A, Second Floor, Bedminster, New Jersey 07921.

The new corporate telephone number is +1 908 947 7777.

The new corporate fax number is +1 908 947 7953.

About Clinsys Clinical Research, Inc.

Clinsys Clinical Research, Inc.(R), is a therapeutically focused clinical research organization and a Jubilant Organosys company, headquartered in Bedminster, New Jersey. Clinsys has operations in Raleigh, North Carolina; Philadelphia, Pennsylvania; Dusseldorf, Germany; Gent, Belgium; Noida and Bangalore, India. Clinsys provides pharmaceutical and biotechnology companies a broad range of clinical research services in support of Phase I -- IV drug development: project management, medical and clinical monitoring, investigator and patient recruitment, site management, biostatistics, data management, drug safety, quality assurance, regulatory affairs and medical writing services. Clinsys has expertise in a wide range of highly specialized therapeutic areas including oncology, cardiovascular, central nervous system, dermatology, respiratory, and allergy/immunology. Clinsys Clinical Research, Ltd., located in Noida, India, provides extensive clinical research services for Phase I -- IV drug development, and operates a clinical pharmacology unit which performs bioavailability and bioequivalence studies as well as bioanalytical sample analysis, clinical laboratory and pathology services. Targeted Clinical Staffing Solutions(R) (TCSS -- gotcss.com), a division of Clinsys Clinical Research, Inc., is a provider of professional staffing solutions and innovative partnering programs for the life sciences industry. For more information visit clinsyscro.com.

About Jubilant Organosys, Ltd.

Jubilant Organosys is an integrated pharmaceutical services provider, one of the largest custom research and manufacturing services (CRAMS), drug discovery and development services companies headquartered in India. Jubilant Organosys has more than 4,300 employees across organizations in India, the United States, Europe and China. It has four manufacturing locations in India and two in the United States. For more information visit jubl.com.

Clinsys Clinical Research and Targeted Clinical Staffing Solutions are registered trademarks of Clinsys Clinical Research, Inc.

Contact: Colin Coffua -- Vice President, Global Marketing

+1 908 464 7500

ccoffua@clinsyscro.com


'/>"/>
SOURCE Clinsys Clinical Research, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioRobot MDx standardize your automated protocols in clinical laboratories
2. What patients want: A story of choice, clinical trials & evidence-based medicine
3. ZyStor seeks to raise $15M for clinical trials
4. Prodesse begins clinical trials for flu virus detection
5. ConjuGon raises $3.3 million to fund clinical trials
6. Cancer-fighting agent heads for clinical trials
7. Quintessence cancer treatment chosen for clinical studies
8. Third Wave reports clinical growth, continued loss
9. Childrens expanding use of Sunrise Clinical Manager
10. Life-sciences conference to feature novel research with clinical potential
11. $14 million grant to drive clinical research at UW
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... A study recently ... in an ambulatory surgery center (ASC) with satisfactory clinical and patient-reported outcomes, when ... studies. , Jake Lubinski, president of AxioMed, commented on the recent publication, ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, a ... a new category of therapeutics, announced today the completion ... in peripheral artery disease. The trial will evaluate the ... therapeutic, in the reduction of restenosis following angioplasty. ... development milestone for SB-030," said Nathan Bachtell , ...
(Date:2/24/2017)... Feb. 24, 2017  VWR Corporation (NASDAQ: VWR), the leading ... and production customers, today reported its financial results for the ... Highlights: 4Q16 record quarterly net ... on an organic basis. 4Q16 ... organic basis, while the Americas net sales increased 2.5%, or ...
(Date:2/23/2017)... , Feb. 23, 2017 /PRNewswire/ - The Fight Against ... Cancer Research (OICR) are pleased to report that Fusion ... financing, with Johnson & Johnson Innovation – JJDC, Inc. ... venture groups HealthCap, TPG Biotechnology Partners, and Genesys Capital, ... ...
Breaking Biology Technology:
(Date:2/8/2017)... YORK , Feb. 7, 2017 Report Highlights ... The ... should reach $11.4 billion by 2021, growing at a compound ... Includes - An overview of the global markets for synthetic ... 2015, estimates for 2016, and projections of compound annual growth ...
(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/6/2017)... , Feb. 6, 2017 According to ... are driving border authorities to continue to embrace ... there are 2143 Automated Border Control (ABC) eGates ... deployed at more than 163 ports of entry ... to 2016 achieving a combined CAGR of 37%. ...
Breaking Biology News(10 mins):